Prostate Cancer News and Research RSS Feed - Prostate Cancer News and Research Twitter

Prostate cancer is the most common non-skin cancer in the United States and the third most common cancer worldwide. More than 1 million men in the United States have prostate cancer and it is the second leading cause of cancer death amongst men after lung cancer. In 2009, an estimated 192,280 new cases are expected to be diagnosed and approximately 27,360 men are expected to die from the disease. Castration-resistant prostate cancer (CRPC) is defined as prostate cancer that continues to grow despite all standard-of-care hormonal (anti-androgen) therapies. Patients with castration-resistant (also known as hormone-refractory) prostate cancer have few treatment options and a poor prognosis.
Further Reading
Non-invasive fluid-based biomarker could help identify aggressive prostate cancer before surgery

Non-invasive fluid-based biomarker could help identify aggressive prostate cancer before surgery

Prostate cancer researchers have discovered biomarkers using non-invasive liquid biopsies to identify aggressive disease before surgery. [More]
Prognostic factor could help identify tumor recurrence after surgery for prostate cancer

Prognostic factor could help identify tumor recurrence after surgery for prostate cancer

Slightly more than 10% of all patients who undergo successful surgery for prostate cancer have an elevated risk of tumor recurrence afterwards - especially as metastases. [More]
NYU Lutheran helps patients fight prostate cancer with latest diagnostic and robotic surgery technology

NYU Lutheran helps patients fight prostate cancer with latest diagnostic and robotic surgery technology

Leading NYU Lutheran's fight is Marc Bjurlin, DO, the hospital's newly appointed director of urologic oncology and clinical assistant professor of urology at NYU School of Medicine. [More]
Vice President Biden to host Cancer Moonshot Summit in Washington, D.C.

Vice President Biden to host Cancer Moonshot Summit in Washington, D.C.

Vice President Biden and Dr. Jill Biden will host a Cancer Moonshot Summit in Washington, D.C. at the White House. Cheryl Willman, MD, Director and CEO of The University of New Mexico Comprehensive Cancer Center, will attend. [More]
KIT researchers develop 3D prostate model based on cryogels

KIT researchers develop 3D prostate model based on cryogels

A team of researchers led by Dr. Friederike J. Gruhl and Professor Andrew C. B. Cato at Karlsruhe Institute of Technology are developing a three-dimensional model for prostate cancer research based on cryogels. [More]
Siemens Healthineers' new CT and MRI technologies to aid research across various common clinical pathways

Siemens Healthineers' new CT and MRI technologies to aid research across various common clinical pathways

The Transforming Outcomes and Health Economics Through Imaging (TOHETI) programme is looking to change the way medical imaging works by undertaking a range of pioneering research. [More]
Adherence to cancer prevention guidelines on diet and physical activity may reduce disease incidence

Adherence to cancer prevention guidelines on diet and physical activity may reduce disease incidence

"Behaviors such as poor diet choices, physical inactivity, excess alcohol consumption and unhealthy body weight could account for more than 20 percent of cancer cases, and could, therefore, be prevented with lifestyle modifications," Kohler said, adding that when tobacco exposure is considered, these modifiable issues are believed to be factors in two-thirds of U.S. cancer deaths. [More]
Patients more likely to develop increased trust when surgeons disclose specialty bias

Patients more likely to develop increased trust when surgeons disclose specialty bias

A doctor's guidance may reassure us more than we realize -especially if she says she is likely to recommend treatment in her field of expertise, known as "specialty bias." [More]
Experts develop set of resolutions, conclusions to provide clarity on testosterone therapy

Experts develop set of resolutions, conclusions to provide clarity on testosterone therapy

In an effort to address widespread concerns related to testosterone deficiency (TD) and its treatment with testosterone therapy, a group of international experts has developed a set of resolutions and conclusions to provide clarity for physicians and patients. [More]
Shorter course of prostate cancer radiotherapy could save NHS millions of pounds

Shorter course of prostate cancer radiotherapy could save NHS millions of pounds

A shorter course of prostate cancer radiotherapy, involving fewer hospital visits and higher individual doses of radiotherapy, is as effective as the current standard treatment for both survival and quality of life, a major new study reports. [More]
Telephone counseling can help make cancer genetic services more accessible to rural women

Telephone counseling can help make cancer genetic services more accessible to rural women

Ever since Angelina Jolie used cancer genetic counseling and testing to learn about her risk for hereditary breast and ovarian cancer, many other women have chosen to do the same. [More]
Scientists identify on/off obesity-induced switch to slow cancer progression

Scientists identify on/off obesity-induced switch to slow cancer progression

Having established that excessive fat tissue can fuel the growth of certain cancers, researchers have turned their attention to the molecular mechanisms involved in the process in the hopes of developing new cancer treatments. [More]
Fetal BPA exposure leads to harmful change in adult uterine response to estrogens

Fetal BPA exposure leads to harmful change in adult uterine response to estrogens

Low levels of BPA exposure may be considered safe, but new research published online in The FASEB Journal, suggests otherwise. In the report, researchers from Yale show that the genome is permanently altered in the uterus of mice that had been exposed to BPA during their fetal development. [More]
Already-approved drugs can fight apoptosis evasion in cancer

Already-approved drugs can fight apoptosis evasion in cancer

Cancer cells don't die when they're supposed to. Animal and human bodies follow an orderly process of birthing new cells and killing old ones. But cancer cells escape programmed cell death, called apoptosis, and multiply uncontrollably. [More]
Nut consumption may lower risk of overall mortality in prostate cancer patients

Nut consumption may lower risk of overall mortality in prostate cancer patients

In a large prospective study published online in the British Journal of Cancer, researchers looked at the association between nut consumption and prostate cancer risk and mortality among 47,299 men in the Health Professionals Follow-up Study. [More]
Screening PSA levels in younger men could accurately predict future risk of prostate cancer

Screening PSA levels in younger men could accurately predict future risk of prostate cancer

Prostate cancer screening with prostate-specific antigen (PSA) has been shown to reduce death and the spread of prostate cancer to other parts of the body, but the PSA test remains highly controversial as it frequently leads to over diagnosis and over treatment of men who may not be at risk. [More]
PI3K/AKT/mTOR pathway plays key role in prostate tumor growth and progression

PI3K/AKT/mTOR pathway plays key role in prostate tumor growth and progression

The research article - Targeting the PI3K/AKT/mTOR Pathway in Prostate Cancer Development and Progression: Insight to Therapy, by Dr Claudio Festuccia and published in Clinical Cancer Drugs, volume 3, issue 1 - discusses experimental and clinical data on the pharmacological inhibition of the Akt/mTOR pathways. [More]
MRI-guided focal laser ablation could be feasible, safe in prostate cancer patients

MRI-guided focal laser ablation could be feasible, safe in prostate cancer patients

Prostate cancer patients may soon have a new option to treat their disease: laser heat. UCLA researchers have found that focal laser ablation - the precise application of heat via laser to a tumor - is both feasible and safe in men with intermediate risk prostate cancer. [More]
UAB receives new image-guided robotic system for early prostate cancer diagnosis

UAB receives new image-guided robotic system for early prostate cancer diagnosis

The world-renowned iSR'obotTM Mona Lisa makes its way to the United States, providing urologic surgeons with a tool to diagnose prostate cancer earlier through accurate diagnosis and precise localization that may allow for targeted treatments in the future. [More]
NaF-PET/CT scans can accurately detect bone metastases in advanced prostate cancer patients

NaF-PET/CT scans can accurately detect bone metastases in advanced prostate cancer patients

A recent pilot study reported in the June issue of The Journal of Nuclear Medicine found that sodium fluoride (Na-F-18) positron emission tomography/computed tomography (NaF-PET/CT) accurately detects bone metastases in patients with advanced prostate cancer, and follow-up scans over time correlate clearly with clinical outcomes and patient survival. [More]
Advertisement